RL

ReShape Lifesciences

HIND
NASDAQHealth Care
$2.30
USD
+0.02(+0.88%)
At close: Jun 12, 20:00 UTC

Open

$2.32

Prev. Close

$2.32

High

$2.32

Low

$2.31

Market Snapshot

Market Cap

$16.14M

P/E Ratio

-1.3

EPS

-2515.10

Revenue

$5.8M

Employees

9

About

Vyome Holdings, Inc. engages in the development of immuno-inflammatory assets. The company is headquartered in San Clemente, California and currently employs 9 full-time employees. The company went IPO on 2016-10-06. The firm is focused on leveraging its clinical-stage assets to transform the lives of patients with immuno-inflammatory conditions. Its clinical program VT1953 Gel is focused on cancer patients who are suffering from malignant fungating wounds (MFW). Its preclinical development program, VT1908, is a non-steroidal eye drop, which is focused on Uveitis. Its other business unit is focused on offering artificial intelligence (AI)-driven healthcare solutions across mental health and inflammation care, digital therapeutics and psychoneuroimmunology.